Delivery Order SPE2DB24D1205-SPE2DB25FCQUX

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Xarelto 20 mg tablets. The contract has a ceiling value of $1,220.66 and an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a ceiling value of $4,013.29 and is a firm fixed-price delivery order type with a period of performance ending on June 27, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xarelto 20 mg tablets, a cardiovascular medication. The contract has a firm fixed price ceiling value of $2,299.67 and a completion date of June 8, 2023. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 15 mg tablets. The contract has a ceiling value of $1,630.96 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Xarelto 20 mg tablet. The contract has a ceiling value of $2,956.91 and is a firm fixed-price delivery order. It is not associated with a set-aside program. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG TABLET 30S. The delivery order has a ceiling value of $1,767.08 and a contract type of Firm Fixed Price. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,217.83, is for the delivery of Xarelto 20 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a ceiling value of $13,215.70 and a completion date of May 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the procurement of Xarelto 20 mg tablets and has a ceiling value of $8,099.87. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $12,302.02 and covers the delivery of Xarelto 20 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCQUX
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a firm fixed-price pricing type and a ceiling value of $21,527.83. The delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 and provides a range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by October 16, 2024.

Generated 1/14/25, 9:15 AM